Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dendreon names new CEO

This article was originally published in Scrip

Executive Summary

Seattle, US-based Dendreon has appointed W Thomas Amick president and chief executive officer of the company – effective immediately. Mr Amick has also been appointed to Dendreon's board of directors. He succeeds John H Johnson, who previously announced his plans to step down as CEO for personal reasons. Mr Johnson will work with Mr Amick through to 15 August 2014 to ensure a smooth transition, Dendreon said. Most recently from 2010 to 2012, Mr Amick was chair and CEO of Discovery Labs, a specialty biotechnology company.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts